These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 17284368
1. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women. Khadang B, Fattahi MJ, Talei A, Dehaghani AS, Ghaderi A. Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368 [Abstract] [Full Text] [Related]
2. Polymorphism of tumor protein p53 codon 72 showed no association with oral lichen planus in Shiraz, Iran. Ghabanchi J, Fattahi MJ, Mardani M, Tadbir AA, Paydar AA. J Craniofac Surg; 2009 Nov; 20(6):2168-70. PubMed ID: 19884837 [Abstract] [Full Text] [Related]
3. Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer. Ghasemi N, Karimi-Zarchi M, Mortazavi-Zadeh MR, Atash-Afza A. Cancer Genet Cytogenet; 2010 Jan 15; 196(2):167-70. PubMed ID: 20082853 [Abstract] [Full Text] [Related]
4. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk. Damin AP, Frazzon AP, Damin DC, Roehe A, Hermes V, Zettler C, Alexandre CO. Cancer Detect Prev; 2006 Jan 15; 30(6):523-9. PubMed ID: 17113725 [Abstract] [Full Text] [Related]
5. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women. Jiang P, Liu J, Zeng X, Li W, Tang J. Cancer Genet Cytogenet; 2010 Mar 15; 197(2):174-8. PubMed ID: 20193851 [Abstract] [Full Text] [Related]
6. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients. Ignaszak-Szczepaniak M, Horst-Sikorska W, Sawicka J, Kaczmarek M, Slomski R. Oncol Rep; 2006 Jul 15; 16(1):65-71. PubMed ID: 16786124 [Abstract] [Full Text] [Related]
7. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer. Hu Y, McDermott MP, Ahrendt SA. Clin Cancer Res; 2005 Apr 01; 11(7):2502-9. PubMed ID: 15814626 [Abstract] [Full Text] [Related]
8. p 53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients. Mojtahedi Z, Haghshenas MR, Hosseini SV, Fattahi MJ, Ghaderi A. Indian J Cancer; 2010 Apr 01; 47(1):31-4. PubMed ID: 20071787 [Abstract] [Full Text] [Related]
9. Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population. Franeková M, Zúbor P, Stanclová A, Dussan CA, Bohusová T, Galo S, Dobrota D, Kajo K, Péc M, Racay P. Neoplasma; 2007 Apr 01; 54(2):155-61. PubMed ID: 17319790 [Abstract] [Full Text] [Related]
10. P53 codon 72 polymorphism in breast cancer. Buyru N, Tigli H, Dalay N. Oncol Rep; 2003 Apr 01; 10(3):711-4. PubMed ID: 12684648 [Abstract] [Full Text] [Related]
11. p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Papadakis EN, Dokianakis DN, Spandidos DA. Mol Cell Biol Res Commun; 2000 Jun 01; 3(6):389-92. PubMed ID: 11032762 [Abstract] [Full Text] [Related]
12. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women. Noma C, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S. Cancer Lett; 2004 Jul 16; 210(2):197-203. PubMed ID: 15183535 [Abstract] [Full Text] [Related]
13. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3. Jha P, Jha P, Pathak P, Chosdol K, Suri V, Sharma MC, Kumar G, Singh M, Mahapatra AK, Sarkar C. Exp Mol Pathol; 2011 Apr 16; 90(2):167-72. PubMed ID: 21115003 [Abstract] [Full Text] [Related]
14. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis. Zhuo XL, Cai L, Xiang ZL, Zhuo WL, Wang Y, Zhang XY. Arch Med Res; 2009 May 16; 40(4):299-305. PubMed ID: 19608020 [Abstract] [Full Text] [Related]
15. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas. Langerød A, Bukholm IR, Bregård A, Lønning PE, Andersen TI, Rognum TO, Meling GI, Lothe RA, Børresen-Dale AL. Cancer Epidemiol Biomarkers Prev; 2002 Dec 16; 11(12):1684-8. PubMed ID: 12496062 [Abstract] [Full Text] [Related]
16. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia. Hadhri-Guiga B, Toumi N, Khabir A, Sellami-Boudawara T, Ghorbel A, Daoud J, Frikha M, Gargouri A, Mokdad-Gargouri R. Cancer Genet Cytogenet; 2007 Oct 15; 178(2):89-93. PubMed ID: 17954263 [Abstract] [Full Text] [Related]
17. An increased lung cancer risk associated with codon 72 polymorphism in the TP53 gene and human papillomavirus infection in Mazandaran province, Iran. Nadji SA, Mahmoodi M, Ziaee AA, Naghshvar F, Torabizadeh J, Yahyapour Y, Nategh R, Mokhtari-Azad T. Lung Cancer; 2007 May 15; 56(2):145-51. PubMed ID: 17208332 [Abstract] [Full Text] [Related]
18. p53 codon 72 polymorphism and HPV status in lung cancer. Buyru N, Altinisik J, Isin M, Dalay N. Med Sci Monit; 2008 Sep 15; 14(9):CR493-7. PubMed ID: 18758421 [Abstract] [Full Text] [Related]
19. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer. Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Xie Y. Clin Cancer Res; 2005 Oct 15; 11(20):7328-33. PubMed ID: 16243804 [Abstract] [Full Text] [Related]
20. TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer. Rogounovitch TI, Saenko VA, Ashizawa K, Sedliarou IA, Namba H, Abrosimov AY, Lushnikov EF, Roumiantsev PO, Konova MV, Petoukhova NS, Tchebotareva IV, Ivanov VK, Chekin SY, Bogdanova TI, Tronko MD, Tsyb AF, Thomas GA, Yamashita S. Oncol Rep; 2006 Apr 15; 15(4):949-56. PubMed ID: 16525684 [Abstract] [Full Text] [Related] Page: [Next] [New Search]